NCT05091567 2026-03-10IMforteHoffmann-La RochePhase 3 Active not recruiting660 enrolled 23 charts 1 FDA
NCT05072106 2025-09-16Study to Evaluate the Effect of Bosentan on the Pharmacokinetics of Lurbinectedin in Patients With Advanced Solid TumorsPharmaMarPhase 1 Completed11 enrolled 26 charts
NCT05063318 2025-09-02Clinical Trial of Lurbinectedin (PM01183) in Patients With Advanced Solid TumorsPharmaMarPhase 1 Completed14 enrolled 20 charts